Skip to main content

Table 2 Univariate analysis of risk factors associated with OS and PFS

From: The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma

Variables

OS

PFS

HR (95% CI)

P value

HR (95% CI)

P value

Age (> 60 vs. ≤ 60)

1.80 (0.98–3.81)

0.065

1.04 (0.52–2.30)

0.205

Gender (male vs. female)

1.45 (1.07–1.92)

0.052

0.29 (0.13–0.86)

0.905

B symptoms (yes vs. no)

0.68 (0.24–1.63)

0.024

0.35 (0.12–1.98)

0.032

Lugano stage (I–II2 vs. III–IV)

2.28 (1.28–4.14)

0.001

1.52 (0.65–3.58)

0.018

LDH (elevated vs. normal)

1.31 (1.04–1.67)

0.015

0.67 (0.33–1.42)

0.327

Local tumor invasiveness (yes vs. no)

0.46 (0.22–0.96)

0.024

0.32 (0.15–0.66)

0.037

Treatment (chemotherapy or radiotherapy vs. both)

0.67 (0.33–1.42)

0.004

0.35 (0.12–2.30)

0.041

Absolute lymphocyte count (≤ 1.5 × 109/L vs. > 1.5 × 109/L)

1.56 (0.72–3.40)

0.002

1.24 (0.62–2.08)

0.006

Absolute monocyte count (≤ 0.5 × 109/L vs. > 0.5 × 109/L)

0.53 (0.21–1.37)

0.102

0.45 (0.13–2.49)

0.361

LMR (≤ 2.7 vs. > 2.7)

4.21 (1.53–11.56)

0.000

2.78 (1.15–6.76)

0.034